financetom
Business
financetom
/
Business
/
Apellis Pharmaceuticals Insider Sold Shares Worth $523,400, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apellis Pharmaceuticals Insider Sold Shares Worth $523,400, According to a Recent SEC Filing
Sep 12, 2025 1:39 PM

04:08 PM EDT, 09/12/2025 (MT Newswires) -- David O. Watson, General Counsel, on September 10, 2025, sold 20,000 shares in Apellis Pharmaceuticals ( APLS ) for $523,400. Following the Form 4 filing with the SEC, Watson has control over a total of 183,866 common shares of the company, with 123,730 shares held directly and 60,136 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000119312525202168/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved